BioPortfolio - EMD LEXIGEN
Having gained independence from Fuji Photo Film in 1997, EMD Lexigen has honed its activities to focus on developing proprietary immunocytokine and Fc-X ...
http://www.bioportfolio.com/biocorporate/22446-EMD_LEXIGEN.h...
|
BioSpace - Lexigen Pharmaceuticals Corp. News, Search Jobs, Events
21 Sep 2001 ... Lexigen has two novel immunocytokines in clinical development. ... the immunocytokine concept as a broad, proprietary technology base. ...
http://www.biospace.com/company_profile.aspx?CompanyId=4269...
|
BioPortfolio - EMD LEXIGEN - Profile
independence from Fuji Photo Film in 1997, EMD Lexigen has honed its activities to ... proprietary immunocytokine and Fc-X fusion protein technologies for ...
http://www.bioportfolio.com/biocorporate/22446-EMD%25252BLEX...
|
Technology evaluation: EMD-273063, EMD Lexigen Ion Niculescu-Duvaz
immunocytokine under development by EMD Lexigen ..... Key references relating to the technology are classified according to a set of standard headings to ...
http://www.biomedcentral.com/content/pdf/cd-563945.pdf...
|
BioPortfolio - EMD Lexigen Research Center - Profile
1997, EMD Lexigen has honed its activities to focus on developing proprietary immunocytokine and Fc-X. fusion protein technologies for treatment of ...
http://www.bioportfolio.com/biocorporate/25645-EMD+Lexigen+R...
|
American Association of Cancer Research - 95th Annual Meeting ...
cytokines' (ATTACK), based on Lexigen's immunocytokine. technology and using Antisoma's antibody huBC1 fused. with IL-12. huBC1 is a humanized antibody that
...
http://www.biomedcentral.com/content/pdf/cd-535831.pdf...
|
BioPortfolio - EMD LEXIGEN - Profile
Lexigen for short) was formed to screen Fuji’s chemical library for drug activities, ... proprietary immunocytokine and Fc-X fusion protein technologies
for ...
http://www.bioportfolio.com/biocorporate/22446-EMD+LEXIGEN.p...
|
Preclinical and clinical development of immunocytokines
(hu14.18-IL-2 (Lexigen Pharmaceuticals Corp) and KS-IL-2 ..... years after the first creation of monoclonal antibodies, this technology has the ...
http://www.biomedcentral.com/content/pdf/cd-495878.pdf...
|
7 selected items - PubMed Results
A novel, humanized anti-ganglioside-GD(2)-IL-2 immunocytokine ... Lexigen Pharmaceuticals Corp., Lexington, MA 02137, USA. sgillies@lexigenpharm.com ...
http://www.ncbi.nlm.nih.gov/pubmed/11326425,10841521,9637539...
|
Cytokines as Drug Targets David W Anderson
subsidiary, Lexigen Pharmaceutical Corp, is developing a. novel immunocytokine, huKS-IL-2, with Scripps Research. Institute, which is a humanized monoclonal ...
http://www.biomedcentral.com/content/pdf/cd-404887.pdf...
|
